Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Phase 2/3 Study Investigating The Pharmacokinetics, Safety, And Efficacy Of Dupilumab In Patients Aged >= 6 Months To <6 Years With Severe Atopic Dermatitis
Principal Investigator (?)
Study Number
F17072
Summary
This study is a 2-part (parts A and B) phase 2/3 study to evaluate the safety, pharmacokinetics (PK) and efficacy of dupilumab in patients 6 months to less than 6 years of age with severe atopic dermatitis (AD). 
Phase (?)
Phase III
Sponsor (?)
Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0